Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation

Toxicology and Applied Pharmacology

Volumn 145, Issue 1, 1997, Pages 10-22

  Warheit, D B ^a   Hansen, J F ^a   Yuen, I S ^a   Kelly, D P ^a   Snajdr, S I ^a   Hartsky, M A ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL IRON; TITANIUM DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DUST; HISTOPATHOLOGY; INHALATION; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; LUNG TOXICITY; MACROPHAGE FUNCTION; MALE; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; RAT;

ANIMALIA;

EID: 0031194355     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8102     Document Type: Article

References (20)

1. Carlton W. W. "Proliferative keratin cyst", a lesion in the lungs of rats following chronic exposure to para-aramid fibrils. Fundam. Appl. Toxicol. 23:1994;304-307.
2. Driscoll K. E. Role of inflammation in the development of rat lung tumors in response to chronic particle exposure. rm particle exposure among rats, mice, and hamsters. Inhal. Toxicol. 8:1996;139-154.
3. Ferin J., Oberdorster G. Biological effects and toxicity assessment of titanium dioxide: Anatase and rutile. Am. Ind. Hyg. Assoc. J. 46:1985;69-72.
4. Heinrich U. Comparative response to long-term particle exposure among rats, mice, and hamsters. Inhal. Toxicol. 8:1996;51-71.
5. Hext P. M. Current perspectives on particulate induced pulmonary tumors. Hum. Exp. Toxicol. 13:1994;700-715.
6. 2. Toxicol. Appl. Pharmacol. 79:1985;179-192.
7. 2. Environ. Res. 41:1986;144-167.
8. Mauderly J. L. Lung overload: The dilemma and opportunities for resolution. Inhal. Toxicol. 8:1996;1-28.
9. P. E. Morrow, 1977, Clearance kinetics of inhaled particles, Respiratory Defense Mechanisms. II. Lung Biology in Health and Disease, 493, Dekker, New York.
10. Morrow P. E. Possible mechanisms to explain dust overloading of the lungs. Fundam. Appl. Toxicol. 10:1988;369-384.
11. Morrow P. E. Chronic inhalation study findings as a basis for proposing a new occupational dust exposure limit. J. Am. Coll. Toxicol. 10:1991;279-290.
12. Morrow P. E. Dust overloading of the lungs: Update and appraisal. Toxicol. Appl. Pharmacol. 113:1992;1-12.
13. 1, U.S. Dept. of Health and Human Services, Washington, DC.
14. Oberdorster G., Ferin J., Morrow P. E. Volumetric loading of alveolar macrophages (AM): A possible basis for diminished AM-mediated clearance. Exp. Lung Res. 18:1992;87-104.
15. Oberdorster G. Lung particle overload: Implications for occupational exposures to particles. Regul. Toxicol. Pharmacol. 27:1995;123-135.
16. Vu V. T. Use of hazard and risk information in risk management decisions: Solid particles and fibers under EPA's TSCA and EPCRA. Inhal. Toxicol. 8:1996;181-191.
17. Warheit D. B., Hill L. H., Brody A. R. Surface morphology and correlated phagocytic capacity of pulmonary macrophages lavaged from the lungs of rats. Exp. Lung Res. 6:1984a;71-82.
18. Warheit D. B., Chang L. Y., Hill L. H., Hook G. E. R., Crapo J. D., Brody A. R. Pulmonary macrophage accumulation and asbestos-induced lesions at sites of fiber deposition. Am. Rev. Respir. Dis. 129:1984b;301-310.
19. Warheit D. B., Carakostas M. C., Hartsky M. A., Hansen J. F. Development of a short-term inhalation bioassay to assess pulmonary toxicity of inhaled particles: Comparisons of pulmonary responses to carbonyl iron and silica. Toxicol. Appl. Pharmacol. 107:1991;350-368.
20. Warheit D. B., Kellar K. A., Hartsky M. A. Pulmonary cellular effects in rats following aerosol exposures to ultrafine Kevlar aramid fibrils: Evidence for biodegradability of inhaled fibrils. Toxicol. Appl. Pharmacol. 116:1992;225-239.